EUVIMEDSkopri EUVIMED
Klinische StudieMultizentrische StudieOpen access · CC BY-NC 4.0

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache

Genaro G Gutierrez, Zachary L McCormick iD, Mitchell P Engle, Christopher A Gilmore iD, Matthew J Pingree iD, Jason E Pope, David J DiBenedetto iD, Narayan R Kissoon iD, Puneet K Sayal, Claire A Zurn, Nathan D Crosby iD, Joseph W Boggs iD

Headache: The Journal of Head and Face Pain · 2025

DOI: 10.1111/head.14948 ↗

At a glance

Klinische Studie in Headache: The Journal of Head and Face Pain, 2025. Written by Genaro G Gutierrez and 11 co-authors. Institution: Pain Specialists of America, Austin, Texas, USA. Major MEDLINE topics: Neuralgia, Outcome Assessment, Health Care, Post-Traumatic Headache, Spinal Nerves. Cited 8 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: SPR Therapeutics.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

The aim of this study was to evaluate the efficacy and safety of a 60‐day peripheral nerve stimulation (PNS) treatment targeting the occipital nerves for reducing pain and improving function in individuals diagnosed with cervicogenic headache or occipital neuralgia.

Background

Headache conditions are prevalent and commonly disabling, and conventional therapeutic strategies are often insufficient. Development of a percutaneous 60‐day PNS treatment has created new opportunities to evaluate PNS of the occipital nerves.

Methods

This study was an institutional review board‐approved, multicenter, prospective, single‐arm study that enrolled participants from October 2022 to March 2024. Participants with cervicogenic headache or occipital neuralgia received a 60‐day PNS treatment targeting the occipital nerves. The primary endpoint was the proportion reporting clinically significant (≥30%) reductions in average pain and/or pain interference at end of treatment (EOT). Additional analysis included the proportion of participants with ≥50% reduction in average pain intensity and/or pain interference and additional outcomes including Patient Global Impression of Change, six‐item Headache Impact Test, and Neck Disability Index.

Results

At EOT, 90% of participants (18/20) met the primary endpoint. Further, 85% (17/20) and 83% (15/18) reported ≥50% reductions in pain and/or pain interference at EOT and 3 months, respectively. Clinically meaningful improvements were observed in functional and headache‐related disability and quality‐of‐life measures. All study‐related adverse events were non‐serious.

Conclusion

Most participants reported significant reductions in pain and/or pain interference following 60‐day PNS targeting the occipital nerves. Outcomes through 3 months demonstrate how 60‐day PNS offers an effective approach for the treatment of headache.

Subjects

MeSH terms (MEDLINE)

NeuralgiaOutcome Assessment, Health CarePost-Traumatic HeadacheSpinal NervesTranscutaneous Electric Nerve StimulationAdultAgedFemaleHumansMaleMiddle AgedProspective Studies

Author keywords

60‐day PNScervicogenic headacheheadacheoccipital nervesoccipital neuralgiaperipheral nerve stimulation

Authors and institutions

  • Pain Specialists of America, Austin, Texas, USA.
  • Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Institute of Precision Pain Medicine, Corpus Christi, Texas, USA.
  • Center for Clinical Research, Winston-Salem, North Carolina, USA.
  • Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Evolve Restorative Center, Santa Rosa, California, USA.

ORCID profiles: Zachary L McCormick, Christopher A Gilmore, Matthew J Pingree, David J DiBenedetto, Narayan R Kissoon, Nathan D Crosby, Joseph W Boggs

Funding

  • SPR Therapeutics

Cite

APA

Gutierrez, G. G., McCormick, Z. L., Engle, M. P., Gilmore, C. A., Pingree, M. J., Pope, J. E., DiBenedetto, D. J., Kissoon, N. R., Sayal, P. K., Zurn, C. A., Crosby, N. D., & Boggs, J. W. (2025). A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14948

Vancouver

Gutierrez GG, McCormick ZL, Engle MP, Gilmore CA, Pingree MJ, Pope JE, et al. A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14948

BibTeX
@article{Gutierrez2025,
  author = {Gutierrez, Genaro G and McCormick, Zachary L and Engle, Mitchell P and Gilmore, Christopher A and Pingree, Matthew J and Pope, Jason E and DiBenedetto, David J and Kissoon, Narayan R and Sayal, Puneet K and Zurn, Claire A and Crosby, Nathan D and Boggs, Joseph W},
  title = {A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2025},
  doi = {10.1111/head.14948}
}
Start for free →